Status:
RECRUITING
A Couple-based Gender-transformative Intervention on IPV Against Infertile Women
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
Beijing Obstetrics and Gynecology Hospital
Conditions:
Infertility, Female
Violence, Domestic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multicenter, open-label, randomized controlled trial conducted at two reproductive medicine centers in Beijing, China. Couples undergoing their first or second in-vitro fertilization (IVF) o...
Detailed Description
Infertility and intimate partner violence (IPV) are significant challenges in sexual and reproductive health, with a notable intersection as infertile women face higher IPV risks. However, the needs o...
Eligibility Criteria
Inclusion
- Couples who are undergoing their first or second IVF/ICSI cycle;
- Couples diagnosed with female-factor infertility;
- Couples who have signed consent.
Exclusion
- Couples who receive donated oocytes, sperm, or embryos;
- Couples diagnosed with severe male-factor infertility or unexplained infertility.
- Couples who are undergoing Preimplantation Genetic Testing (PGT);
- Couples who have not undergone embryo transfer within six months after oocyte retrieval;
- Couples who have severe mental disorders;
- Couples who withdrew from the study.
Key Trial Info
Start Date :
June 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
752 Patients enrolled
Trial Details
Trial ID
NCT06124950
Start Date
June 25 2024
End Date
July 1 2026
Last Update
August 28 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Obstetrics and Gynecology Hospital
Beijing, China
2
Peking University Third Hospital
Beijing, China